Product
AG Regimen
1 clinical trial
2 indications
Indication
Pancreatic AdenocarcinomaIndication
Neoadjuvant ChemotherapyClinical trial
Sequential Use of Nab-paclitaxel Plus Gemcitabine and mFOLFIRINOX as Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer: A Randomized Control StudyStatus: Recruiting, Estimated PCD: 2025-10-20